Senseonics Holdings Inc (AMEX:SENS)
$ 0.444 -0.0051 (-1.14%) Market Cap: 235.71 Mil Enterprise Value: 195.40 Mil PE Ratio: 0 PB Ratio: 12.33 GF Score: 48/100

Senseonics Holdings Inc at Jefferies Healthcare Conference Transcript

Jun 09, 2023 / 01:30PM GMT
Release Date Price: $0.7485 (+1.68%)
Tim Goodnow
Senseonics Holdings, Inc. - President & CEO

Good morning. Thanks for attending. My name is Tim Goodnow, and I serve as the CEO for Senseonics. Senseonics is a medical device-focused company in the space of diabetes technology management, obviously, in the area of continuous glucose monitoring.

Our point of differentiation is we are the technology that is implantable under the skin, and we've focused on a transition of generational improvements in duration of our sensor. We're currently commercializing a six-month sensor and have plans here over the next year to transition that to a one-year duration product.

So we're wholly focused in the diabetes space, although the technology does have applications outside, just given the opportunity, of course, that exists in diabetes glucose monitoring. That, for certain, is our focus.

Our historical perspective has been one of, we are the fourth CGM that actually has FDA approval for commercialization. There are numerous technologies that exist, most of those. The other currently approved products are all what's called

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot